bioMérieux S.A. (OTCMKTS:BMXMF – Get Free Report) shares passed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $121.92 and traded as high as $125.44. bioMérieux shares last traded at $125.44, with a volume of 1 shares trading hands.
bioMérieux Stock Performance
The company has a debt-to-equity ratio of 0.10, a current ratio of 2.21 and a quick ratio of 1.20. The company’s 50-day moving average price is $121.92 and its two-hundred day moving average price is $114.01.
bioMérieux Company Profile
bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.
Featured Stories
- Five stocks we like better than bioMérieux
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Newsmax’s IPO Whiplash: Meme Stock Hype or Growth Potential?
- How to Most Effectively Use the MarketBeat Earnings Screener
- Disney 2025 Shareholders: Major Updates for Investors
- How to Calculate Stock Profit
- Advance Auto Parts Stock: A Classic Rebound Play in the Making
Receive News & Ratings for bioMérieux Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioMérieux and related companies with MarketBeat.com's FREE daily email newsletter.
